FAQ on SOBRsafe Inc.'s New Board Appointment and Scientific Advisor
Summary
Who has SOBRsafe Inc. recently appointed to its Board of Directors?
SOBRsafe Inc. has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM, and PwC, to its Board of Directors effective May 1, 2025.
What role will Kris Pederson play on the SOBRsafe Board?
Kris Pederson will chair the Nominating and Corporate Governance Committee on the SOBRsafe Board of Directors.
Who is Dr. Benjamin Sanchez and what is his role at SOBRsafe?
Dr. Benjamin Sanchez has been named a Scientific Advisor at SOBRsafe to support federal funding and clinical research partnerships.
What is the significance of these appointments for SOBRsafe?
These appointments bring deep expertise in governance, digital innovation, and biomedical engineering to SOBRsafe as it scales its alcohol detection technology platform.
What technology does SOBRsafe offer?
SOBRsafe offers advanced transdermal (touch-based) technology for alcohol detection, requiring no breath, blood, or urine samples, and provides solutions like SOBRcheck for point-of-care screening and SOBRsure for continuous monitoring.
Why is SOBRsafe’s technology important?
SOBRsafe’s technology addresses the need for non-invasive, efficient, and hygienic alcohol misuse prevention and monitoring solutions, which is critical as alcohol misuse is a leading cause of preventable death.
Where can I learn more about SOBRsafe’s technology?
You can learn more about SOBRsafe’s technology by visiting their website at www.SOBRsafe.com.
How can I stay updated on SOBRsafe’s latest news?
The latest news and updates relating to SOBRsafe are available in the company’s newsroom at https://ibn.fm/SOBR.
What markets does SOBRsafe target with its technology?
SOBRsafe targets the behavioral health, judicial, and consumer markets with its alcohol detection technology, offering solutions for licensing and integration.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 113268